{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:10:03Z","timestamp":1761621003344},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1038\/ja.2006.21","type":"journal-article","created":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T11:29:11Z","timestamp":1232364551000},"page":"145-148","source":"Crossref","is-referenced-by-count":10,"title":["FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738"],"prefix":"10.1038","volume":"59","author":[{"given":"Ryuichi","family":"Kanasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumie","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetada","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Fujie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl. 4","key":"BFja200621_CR1","first-page":"S38","volume":"11","author":"JC Wade","year":"1997","unstructured":"Wade JC . Treatment of fungal and other opportunistic infections in immunocompromised patients. Leukemia 11(Suppl. 4): S38\u2013S39 ( 1997)","journal-title":"Leukemia"},{"key":"BFja200621_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","volume":"12","author":"HA Gallis","year":"1990","unstructured":"Gallis HA, Drew RH, Pickard WW . Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12: 308\u2013329 ( 1990)","journal-title":"Rev Infect Dis"},{"key":"BFja200621_CR3","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1097\/00002030-199715000-00008","volume":"11","author":"JD Carledge","year":"1997","unstructured":"Carledge JD, Midgley J, Gazzard BG . Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidiasis. AIDS 11: 1839\u20131844 ( 1997)","journal-title":"AIDS"},{"key":"BFja200621_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ja.2006.20","volume":"59","author":"R Kanasaki","year":"2006","unstructured":"Kanasaki R, Sakamoto K, Hashimoto M, Takase S, Tsurumi Y, Fujie A, Hino M, Hashimoto S, Hori Y . FR209602 and related compounds, novel antifungal lipopeptides from Coleophoma crateriformis No. 738. I. Taxonomy, fermentation, isolation and physico-chemical properties. J Antibiot 59: 137\u2013144 ( 2006)","journal-title":"J Antibiot"},{"key":"BFja200621_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/1568005014606107","volume":"1","author":"J Liu","year":"2001","unstructured":"Liu J, Balasubramanian MK . 1,3-beta-Glucan synthase: a useful target for antifungal drugs. Curr Drug Targets Infect Disord 1: 159\u2013169 ( 2001)","journal-title":"Curr Drug Targets Infect Disord"},{"key":"BFja200621_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.7164\/antibiotics.52.674","volume":"52","author":"M Tomishima","year":"1999","unstructured":"Tomishima M, Ohki H, Yamada A, Takasugi H, Maki K, Tawara S, Tanaka H . FK463, a novel water-soluble echinocandin lipopeptide: synthesis and antifungal activity. J Antibiot 52: 674\u2013676 ( 1999)","journal-title":"J Antibiot"},{"key":"BFja200621_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1586\/14787210.2.3.345","volume":"2","author":"Y Higashiyama","year":"2004","unstructured":"Higashiyama Y, Kohno S . Micafungin: a therapeutic review. Expert Rev Anti Infect Ther 2: 345\u2013355 ( 2004)","journal-title":"Expert Rev Anti Infect Ther"},{"key":"BFja200621_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2165\/00003495-200464090-00004","volume":"64","author":"B Jarvis","year":"2004","unstructured":"Jarvis B, Figgitt DP, Scott LJ . Micafungin. Drugs 64: 969\u2013984 ( 2004)","journal-title":"Drugs"},{"key":"BFja200621_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1439-0507.2002.tb04771.x","volume":"45","author":"OA Cornely","year":"2002","unstructured":"Cornely OA, Schmitz K, Aisenbrey S . The first echinocandin: caspofungin. Mycoses 45: 56\u201360 ( 2002)","journal-title":"Mycoses"},{"key":"BFja200621_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.7164\/antibiotics.47.1084","volume":"47","author":"T Iwamoto","year":"1994","unstructured":"Iwamoto T, Fujie A, Sakamoto K, Tsurumi Y, Shigematsu N, Yamashita M, Hashimoto S, Okuhara M, Kohsaka M . WF11899A, B, and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties. J Antibiot 47: 1084\u20131091 ( 1994)","journal-title":"J Antibiot"},{"key":"BFja200621_CR11","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.7164\/antibiotics.47.1092","volume":"47","author":"T Iwamoto","year":"1994","unstructured":"Iwamoto T, Fujie A, Nitta K, Hashimoto S, Okuhara M, Kohsaka M . WF11899A, B, and C, novel antifungal lipopeptides. II. Biological properties. J Antibiot 47: 1092\u20131097 ( 1994)","journal-title":"J Antibiot"},{"key":"BFja200621_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0014-5793(84)81032-7","volume":"173","author":"ET Sawistowska-Schr\u00f6der","year":"1984","unstructured":"Sawistowska-Schr\u00f6der ET, Kerridge D, Perry H . Echinocandin inhibition of 1,3-\u03b2-D-glucan synthase from Candida albicans. FEBS Lett 173: 134\u2013138 ( 1984)","journal-title":"FEBS Lett"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja200621.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja200621","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja200621.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:11:28Z","timestamp":1684429888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja200621"}},"subtitle":["II. In Vitro and In Vivo Antifungal Activity"],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["BFja200621"],"URL":"https:\/\/doi.org\/10.1038\/ja.2006.21","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}